Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 5

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Feb 7, 2023; 29(5): 780-799
Published online Feb 7, 2023. doi: 10.3748/wjg.v29.i5.780

Full Size Figure Download Figure

Figure 1 Causal model of hepatocellular carcinoma recurrence. The figure was created with BioRender.com.

Citation: Chiang CC, Yeh H, Lim SN, Lin WR. Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(5): 780-799
URL: https://www.wjgnet.com/1007-9327/full/v29/i5/780.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i5.780

Chiang CC, Yeh H, Lim SN, Lin WR. Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma. World J Gastroenterol 2023; 29(5): 780-799 [PMID: 36816628 DOI: 10.3748/wjg.v29.i5.780]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.